The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery

Anesthesia and Analgesia

Volumn 107, Issue 2, 2008, Pages 391-397

  Mengistu, Andinet M ^a   Röhm, Kerstin D ^a   Boldt, Joachim ^a   Mayer, Jochen ^a   Suttner, Stefan W ^a   Piper, Swen N ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; FLUNITRAZEPAM; MIDAZOLAM; PANCURONIUM; SEVOFLURANE; SUFENTANIL; THROMBIN RECEPTOR; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT; HEMOSTATIC AGENT; PLASMA SUBSTITUTE; SERINE PROTEINASE INHIBITOR;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRAIN; DRUG EFFECT; FEMALE; HEART SURGERY; HUMAN; MALE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY; TUBE; AGED; BLOOD CLOTTING PARAMETERS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTIFIBRINOLYTIC AGENTS; APROTININ; BLOOD COAGULATION; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; FEMALE; HEMOSTATICS; HUMANS; MALE; PLASMA SUBSTITUTES; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; POSTOPERATIVE HEMORRHAGE; SERINE PROTEINASE INHIBITORS; THROMBELASTOGRAPHY; TRANEXAMIC ACID;

EID: 49949111684     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e31817b7732     Document Type: Article

References (36)

1. Hall TS, Sines JC, Spotnitz AJ. Hemorrhage related reexploration following open heart surgery: the impact of pre-operative and post-operative coagulation testing. Cardiovasc Surg 2002; 10:146-53
2. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990;76:1680-97
3. Mojcik CF, Levy JH. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg 2001;71:745-54
4. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 2004;30: 1873-81
5. Hartmann M, Sucker C, Boehm O, Koch A, Loer S, Zacharowski K. Effects of cardiac surgery on hemostasis. Transfus Med Rev 2006;20:230-41
6. Mongan PD, Brown RS, Thwaites BK. Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization. Anesth Analg 1998;87: 258-65
7. Casati V, Guzzon D, Oppizzi M, Bellotti F, Franco A, Gerli C, Cossolini M, Torri G, Calori G, Benussi S, Alfieri O. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. J Thorac Cardiovasc Surg 2000;120:520-7
8. Mannucci PM. Hemostatic drugs. N Engl J Med 1998;339:245-53
9. Khan TA, Bianchi C, Voisine P, Sandmeyer J, Feng J, Sellke FW. Aprotinin inhibits protease-dependent platelet aggregation and thrombosis. Ann Thorac Surg 2005;79:1545-50
10. Landis RC, Haskard DO, Taylor KM. New antiinflammatory and platelet-preserving effects of aprotinin. Ann Thorac Surg 2001;72:S1808-13
11. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-65
12. Toth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 2006;96:781-8
13. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003;1:551-8
14. Ray MJ, Marsh NA, Just SJ, Perrin EJ, O'Brien MF, Hawson GA. Preoperative platelet dysfunction increases the benefit of aprotinin in cardiopulmonary bypass. Ann Thorac Surg 1997;63: 57-63
15. Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Smith BR. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 1991;75:563-70
16. Poullis M, Manning R, Laffan M, Haskard DO, Taylor KM, Landis RC. The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1. J Thorac Cardiovasc Surg 2000;120:370-8
17. Clemetson KJ, Clemetson JM. Platelet receptor signalling. Hematol J 2004;5(Suppl 3):S159-63
18. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995;332: 1553-9
19. Kuitunen A, Hiippala S, Vahtera E, Rasi V, Salmenpera M. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery. Acta Anaesthesiol Scand 2005;49:1272-9
20. Blauhut B, Harringer W, Bettelheim P, Doran JE, Spath P, Lundsgaard-Hansen P. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;108: 1083-91
21. Landis RC, Taylor KM. Aprotinin administration in the pericardial cavity does not prevent platelet activation. J Thorac Cardiovasc Surg 2001;122:405-6
22. Tabuchi N, De Haan J, Boonstra PW, Huet RC, van Oeveren W. Aprotinin effect on platelet function and clotting during cardiopulmonary bypass. Eur J Cardiothorac Surg 1994;8:87-90
23. Day JR, Punjabi PP, Randi AM, Haskard DO, Landis RC, Taylor KM. Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery. Circulation 2004;110:2597-600
24. Ferraris VA, Ferraris SP, Singh A, Fuhr W, Koppel D, McKenna D, Rodriguez E, Reich H. The platelet thrombin receptor and postoperative bleeding. Ann Thorac Surg 1998;65:352-8
25. Kozek-Langenecker SA, Mohammad SF, Masaki T, Green W, Kamerath C, Cheung AK. The effects of aprotonin on platelets in vitro using whole blood flow cytometry. Anesth Analg 2000;90:12-6
26. Tenstad O, Williamson HE, Clausen G, Oien AH, Aukland K. Glomerular filtration and tubular absorption of the basic polypeptide aprotinin. Acta Physiol Scand 1994;152:33-50
27. van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CR. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 99:788 -96, 1990; discussion 96-7
28. Kobzar G, Mardla V, Ratsep I, Samel N. Platelet activity before and after coronary artery bypass grafting. Platelets 2006;17: 289-91
29. Khurana S, Mattson JC, Westley S, O'Neill WW, Timmis GC, Safian RD. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med 1997;130:401-11
30. Chandler WL. The thromboelastography and the thromboelastograph technique. Semin Thromb Hemost 1995;21(Suppl 4):1-6
31. Welsby IJ, Jiao K, Ortel TL, Brudney CS, Roche AM, Bennett- Guerrero E, Gan TJ. The kaolin-activated Thrombelastograph predicts bleeding after cardiac surgery. J Cardiothorac Vasc Anesth 2006;20:531-5
32. Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003;96:51-7
33. Brown RS, Thwaites BK, Mongan PD. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo-controlled trial. Anesth Analg 1997;85: 963-70
34. Horrow JC, Van Riper DF, Strong MD, Brodsky I, Parmet JL. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation 1991;84:2063-70
35. Avidan MS, Da Fonseca J, Parmar K, Alcock E, Ponte J, Hunt BJ. The effects of aprotinin on thromboelastography with three different activators. Anesthesiology 2001;95:1169-74
36. Bowbrick VA, Mikhailidis DP, Stansby G. Value of thromboelastography in the assessment of platelet function. Clin Appl Thromb Hemost 2003;9:137-42